Boston Pharmaceuticals
PrivateLast Round
Corporate Funding
Nov 19, 2015
Total Funding Raised
$600M
Company Overview
Boston Pharmaceuticals is a biopharmaceutical company that acquires and develops clinical-stage therapeutic assets to address unmet medical needs in serious diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Boston Pharmaceuticals Comparables
Compare Boston Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Roche Holding | 88% | |
| Novo Nordisk | 84% | |
| Viking Therapeutics, Inc. | 76% | |
Boston Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Corporate Funding | Nov 19, 2015 |
Boston Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Gurnet Point Capital | Corporate Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 3, 2026
Monthly visitors increased 60% MoM.
Boston Pharmaceuticals Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Boston Pharmaceuticals's valuation, stock price, and market status.